New Jersey Qualifying Conditions: Detailed Guide
What conditions qualify for medical marijuana in New Jersey?
New Jersey approves medical marijuana for 18 qualifying conditions including chronic pain, anxiety, PTSD, cancer, migraines, sickle cell anemia, and opioid use disorder. MMJ.com offers telehealth evaluations for $149.99 with same-day certification and a 100% money-back guarantee.## What is the complete list of New Jersey qualifying conditions?
New Jersey's Medical Cannabis Program, managed by the Cannabis Regulatory Commission (CRC) under the Jake Honig Compassionate Use Medical Cannabis Act, recognizes the following qualifying conditions for 2026:
Pain and Musculoskeletal Conditions
- Chronic Pain
- Intractable Skeletal-Muscular Spasticity
- Dysmenorrhea (Severe Menstrual Pain)
Neurological Conditions
- Epilepsy and Seizure Disorders
- Multiple Sclerosis (MS)
- Amyotrophic Lateral Sclerosis (ALS)
- Muscular Dystrophy
- Tourette's Syndrome
Mental Health Conditions
- Anxiety
- Post-Traumatic Stress Disorder (PTSD)
Cancer and Terminal Illness
- Cancer (pain, nausea, appetite loss)
- Terminal Illness (prognosis under 12 months)
Gastrointestinal Conditions
- Inflammatory Bowel Disease (Crohn's Disease, Ulcerative Colitis)
Eye Conditions
Headache Disorders
Infectious Diseases
- HIV/AIDS
Substance Use Treatment
Blood Disorders
- Sickle Cell Anemia (added January 2026 via P.L. 2025, c.223)
About the Qualifying Medical Conditions
Below is information about each qualifying condition and the research that informed New Jersey's decision to include it in the state program.
Chronic Pain and Musculoskeletal Conditions
Chronic pain, intractable skeletal-muscular spasticity, and dysmenorrhea are approved qualifying conditions under New Jersey's medical marijuana program. New Jersey included these conditions based on systematic reviews examining cannabinoid use among patients with chronic pain conditions.
Anxiety
Anxiety is an approved qualifying condition under New Jersey's medical marijuana program. New Jersey explicitly included anxiety based on research examining cannabinoid use in patients with anxiety disorders.
PTSD
PTSD is an approved qualifying condition under New Jersey's medical marijuana program. New Jersey included this condition based on research examining cannabinoid use among patients with PTSD.
Migraines
Migraines are an approved qualifying condition under New Jersey's medical marijuana program. New Jersey included this condition based on research examining cannabis use among migraine patients.
Epilepsy and Seizure Disorders
Seizure disorders, including epilepsy, are approved qualifying conditions under New Jersey's medical marijuana program. New Jersey included these conditions based on clinical trial research examining CBD in patients with treatment-resistant epilepsy.
Multiple Sclerosis and ALS
MS and ALS are approved qualifying conditions under New Jersey's medical marijuana program. New Jersey included these conditions based on clinical research examining cannabinoid use in patients with spasticity and motor symptoms.
Cancer and Terminal Illness
These are approved qualifying conditions under New Jersey's medical marijuana program. New Jersey included these conditions based on research examining cannabinoid use among patients experiencing treatment-related symptoms or end-of-life care needs.
Opioid Use Disorder
Opioid Use Disorder is an approved qualifying condition under New Jersey's medical marijuana program. New Jersey included this condition based on research examining cannabis as a potential harm reduction strategy.
Inflammatory Bowel Disease
Inflammatory bowel disease, including Crohn's Disease and Ulcerative Colitis, is an approved qualifying condition under New Jersey's medical marijuana program. New Jersey included this condition based on clinical research examining cannabis use in IBD patients.
Tourette's Syndrome
Tourette's Syndrome is an approved qualifying condition under New Jersey's medical marijuana program. New Jersey included this condition based on research examining THC use in patients with Tourette's.
Muscular Dystrophy
Muscular Dystrophy is an approved qualifying condition under New Jersey's medical marijuana program as determined by the Cannabis Regulatory Commission.
Glaucoma
Glaucoma is an approved qualifying condition under New Jersey's medical marijuana program. New Jersey included this condition based on early research examining the relationship between cannabinoids and intraocular pressure.
HIV/AIDS
HIV/AIDS is an approved qualifying condition under New Jersey's medical marijuana program. New Jersey included this condition based on research examining cannabinoid use among HIV/AIDS patients.
Sickle Cell Anemia
Sickle cell anemia was added as a qualifying condition in January 2026 through Assembly Bill 913 (P.L. 2025, c.223). New Jersey included this condition based on research examining cannabis for chronic pain management in sickle cell disease.
Medical Disclaimer
This page provides information about New Jersey's qualifying conditions for medical cannabis. The inclusion of a condition in New Jersey's program does not constitute medical advice or a guarantee of therapeutic benefit. Individual results vary. Potential side effects may include dizziness, sedation, and cognitive changes. Always consult a healthcare provider before starting treatment.
Reviewed by MMJ.com Medical Advisory Team Last Updated: March 12, 2026